Waddill William D. sold PTGX
September 22, 2025 · Form 4 insider transaction
Waddill William D. sold 4,000 shares of Protagonist Therapeutics, Inc. at $64.25 per share, a transaction worth $257.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,000
Price
$64.25
Total value
$257.0K
InsiderWaddill William D.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2025
Filing dateSeptember 24, 2025
Shares owned after5,130
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023.